Study Design

SPIROMICS involves the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from people with different stages of Chronic Obstructive Pulmonary Disease, or COPD. Our goal is to evaluate this complex disease from multiple angles, across groups of people, to identify the best practices for care and treatments.

SPIROMICS is funded by the National Heart, Lung, and Blood Institute (NHLBI) and the COPD Foundation and is coordinated by the Collaborative Studies Coordinating Center at The University of North Carolina at Chapel Hill.

Subscribe to about